BIOMAT Database Logo BIOMAT Database Logo

Retraction: uPAR/Cathepsin B Overexpression Reverse Angiogenesis by Rescuing FAK Phosphorylation in uPAR/Cathepsin B Down Regulated Meningioma. 2020

UI MeSH Term Description Entries

Related Publications

Retraction: uPAR/Cathepsin B Overexpression Reverse Angiogenesis by Rescuing FAK Phosphorylation in uPAR/Cathepsin B Down Regulated Meningioma.
January 2020, PloS one,
uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma.
February 2011, PloS one,
PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis.
August 2015, Thrombosis and haemostasis,
Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation.
March 2006, International journal of oncology,
Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma.
June 2011, Cancer gene therapy,
Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma.
January 2004, Neoplasma,
Retraction Note to: uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma.
April 2021, Journal of neuro-oncology,
Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin.
October 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Retraction: Co-Depletion of Cathepsin B and uPAR Induces G0/G1 Arrest in Glioma via FOXO3a Mediated p27Kip1 Upregulation.
January 2020, PloS one,
uPAR and cathepsin B shRNA impedes TGF-β1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway.
December 2012, Cell death & disease,
Copied contents to your clipboard!